News

2016 Jan 19

Dying docs opt for less aggressive end-of-life care

Doctors facing death may be less likely to seek surgery or visit the intensive-care unit during the last six months of their lives, according to a study by Holly Prigerson, Ph.D. Read more

2016 Jan 19

Prognostic factors and the impact of new therapies for CLL

Richard Furman, M.D., discusses therapies for chronic lymphocytic leukemia. Read more

2016 Jan 18

Expert discusses emerging agents and the future of follicular lymphoma

When it comes to treating follicular lymphoma, oncologists must carefully consider treatments, says John P. Leonard, M.D. Read more

Patient Irene Price with Dr. David Nanus

2016 Jan 18

Gene sequencing effort helps pinpoint cancer treatments

Precision medicine is helping cancer patients at Weill Cornell Medicine. Read more

2016 Jan 17

Moonshot to Cure Cancer

Dean Laurie Glimcher, M.D., talks about scientific discoveries combating cancer. Read more

2016 Jan 14

Privacy in the post-genomic era: Impossible

Chris Mason, Ph.D., discusses consumer genomics at a healthcare conference. Read more

Lewis Cantley receiving the Wolf Prize from Israeli president Reuven Rivlin

2016 Jan 14

Cantley among 7 Wolf Prize laureates

Meyer director Lewis Cantley, Ph.D, has been awarded "Israel's Nobel Prize." Read more

2016 Jan 14

Is the cure for cancer real or rhetoric?

Harold Varmus, M.D., comments on Vice President Joe Biden's "moonshot" effort to cure cancer. Read more

2016 Jan 13

Getting a GRASP on the R01 Funding Process

The new Grant Review and Support Program (GRASP) at Weill Cornell Medicine is training assistant professor and instructor level investigators to successfully submit their first National Institutes of Health (NIH) R01 proposal. Read more

2016 Jan 12

Engineering tumor environments for study

Feature on the research of Cornell University member Claudia Fischbach-Teschl, Ph.D. Read more

2016 Jan 11

Increased funding for medical research is a terrific first step

Dean Laurie Glimcher, M.D., pens a piece about federal funding for medical research. Read more

2016 Jan 11

Batting it out of the park

Ph.D. student Katie Gayvert's "Moneyball" approach to cancer involves a computational model to screen for drugs that are too toxic to tolerate. Read more

Dr. Richard Furman and patient Bob Azopardi

2016 Jan 06

Improving the Odds

Feature about the lymphoma program. Read more

2016 Jan 06

Eli Lilly, Pfizer, J&J, AbbVie join $48M bet on NYC cancer drug startup

Director Lewis Cantley, Ph.D., is heading a new pharmaceutical venture. Read more

2016 Jan 04

30 Under 30

Graduate students Kaitlyn Gayvert and Neel Madhukar were named to prestigious Forbes list Read more

2015 Dec 29

Glembatumumab vedotin as a treatment in Triple Negative Breast Cancer

Linda Vahdat, M.D., discusses the antibody drug conjugate glembatumumab vedotin in the treatment of women with triple negative breast cancer. Read more